Journal article

Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]

The Journal of pharmacology and experimental therapeutics, 2025 Apr. Benoist CC, Kawas LH, Zhu M and 6 others.

Study type
Journal article
Subjects
Not classified in PubMed MeSH
Journal
The Journal of pharmacology and experimental therapeutics
Published
2025 Apr
PubMed
PMID 40312093 ↗
DOI
10.1016/j.jpet.2025.103567 ↗
Full text
Free on PubMed Central (PMC13095468) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Dihexa →

Other papers on Dihexa

Review · 2015
The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
Journal article · 2013
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds